Breast Carcinoma — Trials

Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 873
Recruiting: 478
Ph III recruiting: 55
Growth YoY: −2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06782698	Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients(HoPEx-Breast)	active not recruiting	N/A	50	Centro Hospitalar Universitário de Santo AntónioOTHER	1	Jan 20, 2025	clinicaltrials
NCT02167490	Sentinel Node Vs Observation After Axillary Ultra-souND(SOUND)	active not recruiting	N/A	1,560	European Institute of OncologyOTHER